dipyridamole has been researched along with Aortic Valve Stenosis in 25 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Aortic Valve Stenosis: A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The sensitivity and specificity of non-invasive methods--specifically single-photon emission computed tomography (SPECT) dipyridamole-thallium myocardial perfusion--for detecting coronary artery disease (CAD) in patients with severe aortic stenosis remains unclear." | 9.09 | SPECT dipyridamole scintigraphy for detecting coronary artery disease in patients with isolated severe aortic stenosis. ( Avakian, SD; Grinberg, M; Mansur, AP; Meneguetti, JC; Ramires, JA, 2001) |
| "The high-dose dipyridamole echocardiography test was performed in 52 patients with severe aortic stenosis; all patients also underwent coronary angiography, independent of test results, before cardiac operation." | 7.70 | Preoperative assessment of coronary artery disease in aortic stenosis: a dipyridamole echocardiographic study. ( Baroni, M; Biagini, A; Ferrazzi, P; Maffei, S; Paoli, F; Terrazzi, M, 1998) |
| "Dipyridamole echocardiography in patients with aortic stenosis is safe and feasible with good sensitivity and better specificity." | 7.70 | [The role of the echo-dipyridamole test in the diagnosis of coronary disease in patients with associated aortic stenosis]. ( Amadei, G; Baggioni, GF; Carioli, E; Kubbajeh, M, 2000) |
| "Dipyridamole SPECT detects significant coronary artery disease (CAD) in patients without aortic stenosis." | 7.69 | Computer-assisted evaluation of dipyridamole thallium-201 SPECT in patients with aortic stenosis. ( Edlund, B; Eriksson, P; Karp, K; Mooe, T; Rask, P; Wiklund, U, 1994) |
| "Dipyridamole single-photon emission tomography (SPET) is used for the detection of coronary artery disease (CAD) and the method has also been applied in patients with aortic stenosis." | 7.69 | Dipyridamole thallium-201 single-photon emission tomography in aortic stenosis: gender differences. ( Eriksson, NP; Karp, KH; Mooe, T; Rask, LP, 1995) |
| "Dipyridamole echocardiography is a suitable clinical technique for assessing the ischaemic vulnerability of the left ventricle in severe aortic valve stenosis with angiographically normal coronary arteries." | 7.69 | Mechanisms of regional ischaemic changes during dipyridamole echocardiography in patients with severe aortic valve stenosis and normal coronary arteries. ( Baroni, M; Biagini, A; Maffei, S; Palmieri, C; Paoli, F; Terrazzi, M, 1996) |
| "Dipyridamole is a potent vasodilator used in pharmacologic stress testing." | 6.67 | Hemodynamic changes during dipyridamole stress in patients with aortic stenosis. ( Karp, KH; Rask, LP; Teien, DE, 1994) |
| " Relationships between the severity of AS, clinical characteristics, hemodynamic response, serious adverse events (SAE) and MPI parameters were analyzed." | 5.51 | The clinical value and safety of ECG-gated dipyridamole myocardial perfusion imaging in patients with aortic stenosis. ( Liu, FS; Shiau, YC; Wang, SY; Wu, YW, 2019) |
| " We conclude that DPT is safe in patients with aortic valve stenosis and angina pectoris." | 5.30 | The safety of dipyridamole-thallium imaging in patients with critical aortic valve stenosis and angina. ( Bourke, JP; Hawkins, T; Roy, S, 1998) |
| "The sensitivity and specificity of non-invasive methods--specifically single-photon emission computed tomography (SPECT) dipyridamole-thallium myocardial perfusion--for detecting coronary artery disease (CAD) in patients with severe aortic stenosis remains unclear." | 5.09 | SPECT dipyridamole scintigraphy for detecting coronary artery disease in patients with isolated severe aortic stenosis. ( Avakian, SD; Grinberg, M; Mansur, AP; Meneguetti, JC; Ramires, JA, 2001) |
| "Fifteen patients with severe aortic stenosis, normal coronary arteries and normal left ventricular systolic function (ejection fraction>50%) underwent a resting/dipyridamole (0." | 3.74 | Coronary flow reserve in severe aortic valve stenosis: a positron emission tomography study. ( Carpeggiani, C; Glauber, M; L'Abbate, A; Neglia, D; Paradossi, U; Pratali, L, 2008) |
| "The high-dose dipyridamole echocardiography test was performed in 52 patients with severe aortic stenosis; all patients also underwent coronary angiography, independent of test results, before cardiac operation." | 3.70 | Preoperative assessment of coronary artery disease in aortic stenosis: a dipyridamole echocardiographic study. ( Baroni, M; Biagini, A; Ferrazzi, P; Maffei, S; Paoli, F; Terrazzi, M, 1998) |
| "Dipyridamole echocardiography in patients with aortic stenosis is safe and feasible with good sensitivity and better specificity." | 3.70 | [The role of the echo-dipyridamole test in the diagnosis of coronary disease in patients with associated aortic stenosis]. ( Amadei, G; Baggioni, GF; Carioli, E; Kubbajeh, M, 2000) |
| "Dipyridamole SPECT detects significant coronary artery disease (CAD) in patients without aortic stenosis." | 3.69 | Computer-assisted evaluation of dipyridamole thallium-201 SPECT in patients with aortic stenosis. ( Edlund, B; Eriksson, P; Karp, K; Mooe, T; Rask, P; Wiklund, U, 1994) |
| "Dipyridamole single-photon emission tomography (SPET) is used for the detection of coronary artery disease (CAD) and the method has also been applied in patients with aortic stenosis." | 3.69 | Dipyridamole thallium-201 single-photon emission tomography in aortic stenosis: gender differences. ( Eriksson, NP; Karp, KH; Mooe, T; Rask, LP, 1995) |
| "Dipyridamole echocardiography is a suitable clinical technique for assessing the ischaemic vulnerability of the left ventricle in severe aortic valve stenosis with angiographically normal coronary arteries." | 3.69 | Mechanisms of regional ischaemic changes during dipyridamole echocardiography in patients with severe aortic valve stenosis and normal coronary arteries. ( Baroni, M; Biagini, A; Maffei, S; Palmieri, C; Paoli, F; Terrazzi, M, 1996) |
| "In a prospective study, the efficacy of a dipyridamole-aspirin regimen in prevention of thromboembolism was evaluated in 50 patients having isolated aortic valve replacement with the Model 2320 Starr-Edwards prosthesis." | 3.66 | Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis. ( Bowen, TE; Brott, WH; Davia, J; Green, DC; Zajtchuk, R, 1981) |
| "Dipyridamole is a potent vasodilator used in pharmacologic stress testing." | 2.67 | Hemodynamic changes during dipyridamole stress in patients with aortic stenosis. ( Karp, KH; Rask, LP; Teien, DE, 1994) |
| " Relationships between the severity of AS, clinical characteristics, hemodynamic response, serious adverse events (SAE) and MPI parameters were analyzed." | 1.51 | The clinical value and safety of ECG-gated dipyridamole myocardial perfusion imaging in patients with aortic stenosis. ( Liu, FS; Shiau, YC; Wang, SY; Wu, YW, 2019) |
| " We conclude that DPT is safe in patients with aortic valve stenosis and angina pectoris." | 1.30 | The safety of dipyridamole-thallium imaging in patients with critical aortic valve stenosis and angina. ( Bourke, JP; Hawkins, T; Roy, S, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (40.00) | 18.7374 |
| 1990's | 7 (28.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, FS | 1 |
| Wang, SY | 1 |
| Shiau, YC | 1 |
| Wu, YW | 1 |
| Carpeggiani, C | 1 |
| Neglia, D | 1 |
| Paradossi, U | 1 |
| Pratali, L | 1 |
| Glauber, M | 1 |
| L'Abbate, A | 1 |
| Nemes, A | 3 |
| Forster, T | 3 |
| Varga, A | 1 |
| Vass, A | 1 |
| Borthaiser, A | 1 |
| Pálinkás, A | 1 |
| Csanády, M | 3 |
| Kovács, Z | 2 |
| Thury, A | 2 |
| Ungi, I | 1 |
| Boda, K | 1 |
| Thormann, J | 1 |
| Brott, WH | 1 |
| Zajtchuk, R | 1 |
| Bowen, TE | 1 |
| Davia, J | 1 |
| Green, DC | 1 |
| Rask, LP | 2 |
| Karp, KH | 2 |
| Teien, DE | 1 |
| Rask, P | 1 |
| Karp, K | 1 |
| Edlund, B | 1 |
| Eriksson, P | 1 |
| Mooe, T | 2 |
| Wiklund, U | 1 |
| Eriksson, NP | 1 |
| Baroni, M | 2 |
| Maffei, S | 2 |
| Terrazzi, M | 2 |
| Palmieri, C | 1 |
| Paoli, F | 2 |
| Biagini, A | 2 |
| Ferrazzi, P | 1 |
| Roy, S | 1 |
| Hawkins, T | 1 |
| Bourke, JP | 1 |
| Amadei, G | 1 |
| Carioli, E | 1 |
| Kubbajeh, M | 1 |
| Baggioni, GF | 1 |
| Avakian, SD | 1 |
| Grinberg, M | 1 |
| Meneguetti, JC | 1 |
| Ramires, JA | 1 |
| Mansur, AP | 1 |
| Demirkol, MO | 1 |
| Yaymaci, B | 1 |
| Debeş, H | 1 |
| Başaran, Y | 1 |
| Turan, F | 1 |
| Blass, KE | 2 |
| Triebe, G | 2 |
| Traub, F | 1 |
| Förster, W | 2 |
| Kupper, W | 1 |
| Bleifeld, W | 1 |
| Hanrath, P | 1 |
| Hamm, C | 1 |
| Mathey, D | 1 |
| Steele, P | 1 |
| Weily, H | 1 |
| Davies, H | 1 |
| Ppppas, G | 1 |
| Genton, E | 1 |
| Georgeson, S | 1 |
| Meyer, KB | 1 |
| Pauker, SG | 1 |
| Huikuri, HV | 1 |
| Korhonen, UR | 1 |
| Ikäheimo, MJ | 1 |
| Heikkilä, J | 1 |
| Takkunen, JT | 1 |
| Mackay, A | 1 |
| de Bono, DP | 1 |
| Wussling, M | 1 |
| Szymanski, G | 1 |
| Schrör, K | 1 |
| Matloff, JM | 1 |
1 review available for dipyridamole and Aortic Valve Stenosis
| Article | Year |
|---|---|
Surgery for aortic valve disease.
Topics: Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Animals; Anticoagulants; Aortic Valve Insufficienc | 1971 |
3 trials available for dipyridamole and Aortic Valve Stenosis
| Article | Year |
|---|---|
Hemodynamic changes during dipyridamole stress in patients with aortic stenosis.
Topics: Aged; Aortic Valve Stenosis; Blood Pressure; Cardiac Catheterization; Cardiac Output; Dipyridamole; | 1994 |
SPECT dipyridamole scintigraphy for detecting coronary artery disease in patients with isolated severe aortic stenosis.
Topics: Aged; Aortic Valve Stenosis; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Dipyrida | 2001 |
Dipyridamole myocardial perfusion tomography in patients with severe aortic stenosis.
Topics: Aged; Aortic Valve Stenosis; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Di | 2002 |
21 other studies available for dipyridamole and Aortic Valve Stenosis
| Article | Year |
|---|---|
The clinical value and safety of ECG-gated dipyridamole myocardial perfusion imaging in patients with aortic stenosis.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Dipyridamole; Electrocardiography; Female; Follow-Up | 2019 |
Coronary flow reserve in severe aortic valve stenosis: a positron emission tomography study.
Topics: Aged; Aortic Valve; Aortic Valve Stenosis; Coronary Circulation; Dipyridamole; Echocardiography, Dop | 2008 |
How can coronary flow reserve be altered by severe aortic stenosis?
Topics: Adult; Aged; Aortic Valve Stenosis; Arteries; Blood Pressure; Coronary Artery Disease; Coronary Circ | 2002 |
The effect of aortic valve replacement on coronary flow reserve in patients with a normal coronary angiogram.
Topics: Aged; Aortic Valve Stenosis; Blood Flow Velocity; Cardiac Volume; Coronary Angiography; Coronary Cir | 2002 |
The comparative value of the aortic atherosclerosis and the coronary flow velocity reserve evaluated by stress transesophageal echocardiography in the prediction of patients with aortic stenosis with coronary artery disease.
Topics: Aged; Aorta; Aortic Valve Stenosis; Blood Flow Velocity; Coronary Angiography; Coronary Artery Disea | 2003 |
[Effect of tachycardia on hemodynamics and coronary circulation. Different relevance of ventricular tachycardias for healthy persons, coronary patients and patients with left heart hypertrophy].
Topics: Aortic Valve; Aortic Valve Stenosis; Cardiac Pacing, Artificial; Cardiomegaly; Coronary Circulation; | 1984 |
Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
Topics: Adult; Aged; Aortic Valve; Aortic Valve Stenosis; Aspirin; Bioprosthesis; Dipyridamole; Drug Therapy | 1981 |
Computer-assisted evaluation of dipyridamole thallium-201 SPECT in patients with aortic stenosis.
Topics: Adult; Aged; Aortic Valve Stenosis; Coronary Angiography; Coronary Disease; Dipyridamole; Echocardio | 1994 |
Dipyridamole thallium-201 single-photon emission tomography in aortic stenosis: gender differences.
Topics: Aged; Aortic Valve Stenosis; Case-Control Studies; Coronary Disease; Dipyridamole; Female; Humans; I | 1995 |
Mechanisms of regional ischaemic changes during dipyridamole echocardiography in patients with severe aortic valve stenosis and normal coronary arteries.
Topics: Adult; Aged; Aortic Valve; Aortic Valve Stenosis; Coronary Disease; Dipyridamole; Echocardiography; | 1996 |
Preoperative assessment of coronary artery disease in aortic stenosis: a dipyridamole echocardiographic study.
Topics: Aortic Valve Stenosis; Blood Pressure; Coronary Disease; Dipyridamole; Echocardiography; Heart Rate; | 1998 |
The safety of dipyridamole-thallium imaging in patients with critical aortic valve stenosis and angina.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Aortic Valve Stenosis; Coronary Angiography; Coronary Dise | 1998 |
[The role of the echo-dipyridamole test in the diagnosis of coronary disease in patients with associated aortic stenosis].
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Chi-Square Distribution; Coronary Angiography; Coron | 2000 |
Influence of long-term treatment with dipyridamole on the aorta-stenosed rabbit heart: morphometric and functional investigations.
Topics: Animals; Aortic Valve Stenosis; Blood Pressure; Cardiomegaly; Dipyridamole; Disease Models, Animal; | 1976 |
[Circulatory and metabolic action of pressure-induced cardiac hypertrophy in rest, during exercise and following medicinal dilatation of the coronary vessels].
Topics: Aortic Valve Stenosis; Cardiomegaly; Coronary Circulation; Dipyridamole; Humans; Lactates; Oxygen; P | 1977 |
Platelet survival time following aortic valve replacement.
Topics: Adult; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Aspirin; Blood Platelets; Ce | 1975 |
Decision analysis in clinical cardiology: when is coronary angiography required in aortic stenosis?
Topics: Angiography; Aortic Valve; Aortic Valve Stenosis; Coronary Angiography; Coronary Disease; Cost-Benef | 1990 |
Detection of coronary artery disease by thallium imaging using a combined intravenous dipyridamole and isometric handgrip test in patients with aortic valve stenosis.
Topics: Aged; Aortic Valve Stenosis; Blood Pressure; Coronary Circulation; Coronary Disease; Dipyridamole; F | 1987 |
Valvar aortic stenosis in adults: an update.
Topics: Adult; Anticoagulants; Aortic Valve Stenosis; Aspirin; Calcinosis; Dipyridamole; Echocardiography; E | 1986 |
[Influence of long-term treatment with dipyridamole on the contractility and development of hypertrophy in rabbit heart with aortic stenois].
Topics: Animals; Aortic Valve Stenosis; Blood Pressure; Body Weight; Cardiomegaly; Dipyridamole; Female; Hea | 1972 |
The influence of hypertrophy and hypoxia on potentiation phenomena of the rabbit papillary muscle tested by a double rest programme.
Topics: Animals; Aortic Valve Stenosis; Calcium; Cardiomegaly; Dipyridamole; Electric Stimulation; Heart Ven | 1974 |